Skip to main content

Table 4 Optimization of GMP and PGH pellets

From: Development and characterization of multiparticulate system as an alternative to unit dosage forms containing drugs with diverse release profiles

Batch Code

% Drug content

%CDR after 60 min

GMP

PGH

GMP

PGH

B1

95.05 ± 2.11

93.42 ± 1.85

94.19 ± 3.64

95.28 ± 4.18

B2

95.22 ± 1.22

93.16 ± 2.31

94.05 ± 2.16

95.90 ± 3.25

B3

95.22 ± 2.05

93.01 ± 1.96

95.01 ± 2.35

94.81 ± 2.19

B4

94.30 ± 2.10

94.98 ± 2.61

93.69 ± 2.45

95.06 ± 2.05

B5

96.02 ± 2.60

95.23 ± 1.79

99.87 ± 1.96

98.13 ± 2.76

B6

94.25 ± 1.78

94.15 ± 1.50

95.11 ± 2.20

95.11 ± 2.20

B7

93.01 ± 1.21

94.90 ± 2.02

98.82 ± 1.14

97.51 ± 2.23

B8

92.12 ± 2.37

91.07 ± 2.08

93.12 ± 2.10

92.92 ± 3.81

B9

94.09 ± 1.77

95.93 ± 2.54

97.82 ± 2.47

94.05 ± 2.91

  1. Values are mean ± SD, n = 3